Bioxcel Therapeutics shares owned by Hennion & Walsh Asset Management
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Hennion & Walsh Asset Management
from 13F filings
Historical chart of Hennion & Walsh Asset Management investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Hennion & Walsh Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $106k | 37k | 2.82 |
| 2023-12-31 | $108k | 37k | 2.95 |
| 2023-09-30 | $86k | 34k | 2.53 |
| 2023-06-30 | $119k | 18k | 6.65 |
| 2023-03-31 | $707k | 38k | 18.66 |
| 2022-12-31 | $842k | 39k | 21.49 |
| 2022-09-30 | $405k | 34k | 11.83 |
| 2022-06-30 | $458k | 35k | 13.20 |
| 2022-03-31 | $736k | 35k | 20.90 |
| 2021-12-31 | $701k | 35k | 20.32 |
| 2021-09-30 | $982k | 32k | 30.36 |
| 2021-06-30 | $618k | 21k | 29.06 |
More positions owned by Hennion & Walsh Asset Management
View all positions for Hennion & Walsh Asset Management